Delivery Order SPE2DE24DA010-SPE2D626F07UJ
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $25,875.85 fixed-price delivery order (Contract No. 4570444146, GALLANT) by the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with performance completion targeted for January 13, 2026. The award was made without set-aside designation through full and open competition and will be performed in Santa Clara, California. This delivery order represents a discrete procurement action under Abbott's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a $34,732.80 fixed-price delivery order (Contract 4570380875, GALLANT) from the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with completion targeted for January 6, 2026. The delivery order, issued without set-aside designation, will be performed in Santa Clara, California, and represents a task order execution under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award (Contract No. 4570376636, designated "GALLANT") from the Defense Logistics Agency Medical Supply Chain on December 30, 2025, with a ceiling value of $37,127.95 and an ultimate completion date of January 5, 2026. The contract utilizes a fixed-price structure with economic price adjustment pricing and will be performed in Santa Clara, California. No set-aside designation was used in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order on December 31, 2025, under contract number 4570556639 (GALLANT) with a fixed ceiling value of $25,875.85. This delivery order, issued by the Defense Logistics Agency's Medical Supply Chain, represents a continuation of Abbott's substantial federal contracting presence in cardiovascular medical technologies. The award carries no set-aside designation and was issued under a fixed-price structure with...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $25,875.85 on December 11, 2025, under a fixed-price contract with economic price adjustment terms. The award, designated as contract number 4570382323 (GALLANT), is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused procurement entity supporting the Department of Defense's medical device and equipment requirements. The place of performance is located...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $28,350 from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. Performance will take place in Santa Clara, California, where Abbott maintains...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F07UJDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $38,645.80 under contract number 4570509253 (GALLANT) from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026. The delivery order utilizes a fixed price with economic price adjustment pricing structure and carries no set-aside designation, reflecting Abbott's competitive positioning in federal healthcare procurement. Performance is scheduled for completion by January 20, 2026, with work to be performed at Abbott's Santa Clara, California location. This award represents a discrete task order issued under one of the Defense Logistics Agency's larger indefinite delivery contracts through which Abbott supplies cardiovascular procedural packages, devices, instrumentation, and accessories to support military and federal healthcare operations. Abbott Vascular has established itself as a critical federal supplier of advanced cardiovascular medical technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, left ventricular assist devices, and transcatheter valve repair systems. The company maintains a substantial presence across the Department of Veterans Affairs' regional Integrated Service Networks and serves as a strategic partner to the Defense Health Agency and other federal healthcare agencies. This delivery order award reflects Abbott's ongoing role in maintaining the medical supply infrastructure necessary to support complex cardiac procedures and enhance patient outcomes across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.6k | 1/6/26 |